金斯瑞生物科技涨超3% CARVYKTI 第三季度产生贸易销售净额约5.24亿美元

Group 1 - Kingsray Biotechnology (01548) saw a stock increase of over 3%, currently trading at 16.27 HKD with a transaction volume of 32.066 million HKD [1] - On October 14, Kingsray Biotechnology announced that, according to the collaboration and licensing agreement with Janssen Biotech, Inc. established on December 21, 2017, CARVYKTI is projected to generate net trade sales of approximately 524 million USD for the quarter ending September 30, 2025 [1]